Proprietary yeast-based technology platform for producing and delivering RNA with applications in multiple large-scale global industries Canada, YVR — Renaissance BioScience Corp. is pleased to announce that it has been… Read More
Patients share experiences of confusion, fear and fragmented care in managing pregnancies at risk for hemolytic disease of the fetus and newborn (HDFN) or fetal neonatal alloimmune thrombocytopenia (FNAIT) under… Read More
NORTH CHICAGO, Ill. – AbbVie announced updated results from the Phase 2 EPCORE® NHL-6 trial (NCT05451810) evaluating the feasibility of dosing and monitoring patients in the outpatient setting for the first… Read More
Vancouver, BC – Kardium Inc., a private medical device company that’s advancing the way the world treats atrial fibrillation (AF), announced it has received pre-market approval (PMA) for the Globe® Pulsed Field… Read More
VANCOUVER, BC – Zymeworks Inc. a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and… Read More
